Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 349-351 , July 2009

Planned renal allograft transplantation after tumor excision: Increasing the availability of living-donor kidneys

References 

  1. Cohn JA, Englesbe MJ, Wolf JS. Can urologic oncologists help expand the renal donor pool with “restored” kidneys?. Urol Oncol. 2008;26:573–574
  2. Whitson JM, Stackhouse GB, Freise CE, et al. Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation. Urology. 2007;70:1007;e1–3
  3. Nicol DL, Preston JM, Wall DR, et al. Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU Int. 2008;102:188–192
  4. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-Year follow-up. J Urol. 2000;163:442–445
  5. McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816–820
  6. Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: An emerging quality of care concern?. J Urol. 2006;175:853–857
  7. Buell JF, Hanaway MJ, Thomas M, et al. Donor kidneys with small renal cell cancers: Can they be transplanted?. Transplant Proc. 2005;37:581–582
  8. Uzzo R, Novick A. Nephron sparing surgery for renal tumors: Indications, techniques, and outcomes. J Urol. 2001;166:6–18
  9. Bani-Hani AH, Leibovich BC, Lohse CM, et al. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol. 2005;173:391–394
  10. Ries LAG, Harkins D, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: National Cancer Institute http://seer.cancer.gov/csr/1975_2001/, based on November 2005 SEER data submission.
  11. Abecassis M, Adams M, Adams P, et al. Consensus statement on the live organ donor. JAMA. 2000;284:2919–2926
  12. Adams PL, Cohen DJ, Danovitch GM, et al. The nondirected live-kidney donor: Ethical considerations and practice guidelines: A National Conference Report. Transplantation. 2002;74:582–589
  13. Spital A. Public attitudes toward kidney donation by friends and altruistic strangers in the United States. Transplantation. 2001;27:1061–1064
  14. Hafez KS, Fergany AF, Novick . Nephron sparing surgery for localized renal cell carcinoma: Impact of tumor size on patient survival, tumor recurrence, and TNM staging. J Urol. 1999;162:1930–1933
  15. Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-Year follow-up. J Urol. 1999;161:33–34
  16. Belldegrun A, Tsui KH, deKernion JB, et al. Efficacy of nephron-sparing surgery for renal cell carcinoma: Analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. 1999;17:2868–2875
  17. Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Clin Proc. 2000;75:1236–1242
  18. Lee CT, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730–736
  19. Puppo P, Introini C, Calvi P, et al. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: Review of 94 cases. Eur Urol. 2004;46:477–481
  20. Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004;171:2181–2185
  21. Lapini A, Serni S, Minervini A, et al. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: Experience in 107 patients. J Urol. 2005;174:57–60
  22. Pahernik S, Roos F, Hampel C, et al. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 Years of experience. J Urol. 2006;175:2027–2031

PII: S1078-1439(09)00086-6

doi: 10.1016/j.urolonc.2009.03.012

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 349-351 , July 2009